Roche Study Shows AI Can Detect Severity of Diabetic Macular Edema

The study, Roche said, adds to the growing amount of scholarly information about the use of artificial intelligence in ophthalmology. The study sheds light on how a company such as Roche and its Genentech subsidiary can use its clinical trial database to develop AI algorithms to predict the presence of disease, risk of disease progression, and response to treatment; all of which could be supplied to ophthalmologists to deliver higher quality personalized healthcare.
Read more...

;